Antioxidant, Antimicrobial, and Molecular Binding Affinity Applications of Green‐Synthesized Nickel Oxide Nanoparticles
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202502684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Kuruvalli Gouthami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, REVA University, Rukmini Knowledge Park, Bangalore, India. Hauptthemen laut MEDLINE: Nickel, Antioxidants, Anti-Bacterial Agents, Antifungal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea (NRF) grants funded by the Korean government, FCT-Fundação para a Ciência e a Tecnologia, I.P..
Abstract (Originalsprache)
The preparation of metal or metal oxide nanoparticles (NPs) using the green method is rapid, low‐cost, and eco‐friendly. In this study, nickel oxide NPs (NiO NPs) were synthesized using Foeniculum vulgare seed extract. The green‐synthesized NiO NPs were characterized by X‐ray diffraction, X‐ray photoelectron spectroscopy, Fourier‐transform infrared spectroscopy, scanning electron microscopy (SEM), and transmission electron microscopy (TEM) techniques. SEM and TEM images revealed spherical and sheet‐like morphologies. The NiO NPs exhibited notable antioxidant, antimicrobial, and molecular interaction properties. Antioxidant activity was evaluated using DPPH + and ABTS + assays, showing IC 50 values of 12.68 ± 0.56 and 11.82 ± 0.84 µg/mL, respectively, compared to standard antioxidants ascorbic acid (8.94 ± 2.2 µg/mL) and gallic acid (1.2 ± 0.67 µg/mL). Antibacterial assays against Staphylococcus aureus , Bacillus sp., Pseudomonas aeruginosa , and Escherichia coli revealed concentration‐dependent inhibition, with maximum zones of inhibition at 80 µg/mL, measuring 7.86 mm for E. coli and 7.21 mm for S. aureus . Antifungal activity showed dose‐dependent inhibition of Aspergillus niger (6.00–7.96 mm) but minimal effect on Fusarium sp. (6.00–6.03 mm), compared to ketoconazole controls (9.36 and 9.21 mm, respectively). Molecular docking revealed strong binding affinities of NiO NPs with P. aeruginosa (−9.9 kcal/mol) and A. niger endoglucanase (−8.5 kcal/mol), comparable to streptomycin (−11.1 kcal/mol) and ketoconazole (−10.0 kcal/mol). These findings highlight the promising antioxidant and antimicrobial potential of NiO NPs for biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, REVA University, Rukmini Knowledge Park, Bangalore, India.
- School of Mechanical Engineering, Yeungnam University, Gyeongsan, Republic of Korea.
- Sri YKR Degree College, SPSR, Nellore, India.
- Department of Biotechnology, REVA University, Rukmini Knowledge Park, Bangalore, India.
- Department of Physics, i3n, University of Aveiro, Aveiro, Portugal.
Förderung
- National Research Foundation of Korea (NRF) grants funded by the Korean government
- FCT-Fundação para a Ciência e a Tecnologia, I.P.
Zitieren
APA
Gouthami, K., Nagajyothi, P. C., Vijaya, R., Maity, S., Santra, A., Pavani, K., Damodara Reddy, V., & Shim, J. (2026). Antioxidant, Antimicrobial, and Molecular Binding Affinity Applications of Green‐Synthesized Nickel Oxide Nanoparticles. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502684
Vancouver
Gouthami K, Nagajyothi PC, Vijaya R, Maity S, Santra A, Pavani K, et al. Antioxidant, Antimicrobial, and Molecular Binding Affinity Applications of Green‐Synthesized Nickel Oxide Nanoparticles. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202502684
BibTeX
@article{Gouthami2026,
author = {Gouthami, Kuruvalli and Nagajyothi, P C and Vijaya, R and Maity, Subhasish and Santra, Ayantika and Pavani, K and Damodara Reddy, Vaddi and Shim, Jaesool},
title = {Antioxidant, Antimicrobial, and Molecular Binding Affinity Applications of Green‐Synthesized Nickel Oxide Nanoparticles},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202502684}
}
EUVIMED